Mawer Investment Management Ltd. Invests $9.45 Million in Medline $MDLN

Mawer Investment Management Ltd. acquired a new position in shares of Medline (NASDAQ:MDLN) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 225,000 shares of the company’s stock, valued at approximately $9,450,000.

Other institutional investors also recently bought and sold shares of the company. Sound Income Strategies LLC purchased a new position in Medline in the fourth quarter worth $25,000. Entrust Financial LLC acquired a new position in shares of Medline during the fourth quarter worth $26,000. NBC Securities Inc. purchased a new stake in shares of Medline during the 4th quarter valued at $28,000. Global Retirement Partners LLC purchased a new stake in shares of Medline during the 4th quarter valued at $31,000. Finally, North Star Investment Management Corp. acquired a new stake in shares of Medline in the 4th quarter worth $36,000.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Wells Fargo & Company upped their target price on Medline from $42.00 to $47.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Tigress Financial raised their price target on Medline from $60.00 to $62.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Morgan Stanley boosted their price target on Medline from $48.00 to $52.00 and gave the stock an “overweight” rating in a research note on Monday, March 2nd. Evercore restated an “outperform” rating and set a $55.00 price objective on shares of Medline in a report on Wednesday, February 25th. Finally, BNP Paribas Exane decreased their price objective on shares of Medline from $49.00 to $40.00 and set a “neutral” rating for the company in a research report on Thursday, May 14th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $50.65.

Medline Price Performance

NASDAQ MDLN opened at $35.75 on Tuesday. The firm’s fifty day simple moving average is $42.14. Medline has a 1 year low of $34.34 and a 1 year high of $50.88.

Medline (NASDAQ:MDLN) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.04. The company had revenue of $7.35 billion for the quarter. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. On average, equities analysts predict that Medline will post 1.5 EPS for the current fiscal year.

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.